SAN FRANCISCO -- It was one of those impenetrable research papers full of statistics and six-syllable words. But its stark conclusion could have cut medication costs for millions of people and might have disrupted a billion-dollar deal.

If only it had been published.

The paper concerned a drug called Synthroid, the main product of British...